SIGA Technologies

$13.68 0.00% ($0.00)

Get ready to invest

About SIGA Technologies

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on health security market. The Company’s lead product TPOXX is approved by the Unites States Food and Drug Administration (FDA) as a drug with an indication for treatment of smallpox. TPOXX is an oral formulation, which is also known as tecovirimat and ST-246. The Company is developing the intravenous (IV) formulation for patients who are unable to swallow oral capsules. It is also focused on developing post-exposure prophylaxis (PEP), liquid suspension pediatric formulation and ST-357. PEP regimens are designed to prevent infection in individuals who have known or exposure to an infectious agent but are not symptomatic. The Company is developing a second mechanism of action smallpox small molecule antiviral drug that has shown efficacy in animal models of the disease.

Popular Stocks	Price	Change
Nu Holdings NU	$4.03 14.16%	14.16%
AMC AMC	$14.43 17.99%	17.99%
AMD AMD	$102.26 3.55%	3.55%
Nvidia NVDA	$188.11 5.38%	5.38%
Gap, Inc., The GPS	$11.6 4.32%	4.32%
Snap SNAP	$15.58 5.2%	5.2%
Ford F	$13.63 3.89%	3.89%
Apple AAPL	$149.64 4.08%	4.08%
Grab Holdings inc. GRAB	$2.41 3.88%	3.88%
NIO NIO	$16.57 3.37%	3.37%